Citi Maintains a 'Neutral' on Regeneron Pharma (REGN); Doctors Consider Eylea as Replacement for Roche's Lucentis

Go back to Citi Maintains a 'Neutral' on Regeneron Pharma (REGN); Doctors Consider Eylea as Replacement for Roche's Lucentis
Regeneron (NASDAQ: REGN) Delayed: 840.84 --0 (-0%)
Previous Close $840.84    52 Week High $592.36 
Open $840.84    52 Week Low $325.35 
Day High $840.84    P/E 220.69 
Day Low $840.84    EPS $3.81 
Volume 758       

Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 58.20 --0 (-0%)
Previous Close $58.20    52 Week High $35.13 
Open $58.20    52 Week Low $28.10 
Day High $58.20    P/E N/A 
Day Low $58.20    EPS $0.00 
Volume 871